In glioblastoma, for example, the lncRNATPT1-AS1 can promote growth activity through the sequestration of miR-23a-5p(Gao et al. 2021), whereas the lncRNA FLVCR1-AS1 can enhance cervical cancer cell malignancy via the miR-23a-5p/SLC7A11 axis(Zhou et al. 2022) and hepatoblastoma progression is at least partially driven by the SNHG9/miR-23a-5p/Wnt3a signaling pathway(Feng et al. 2021). The gene discussed is SNHG9; the disease is hepatoblastoma.